Spinal cord stimulation suppresses focal rapid firing-induced atrial fibrillation by inhibiting atrial ganglionated plexus activity

Journal of Cardiovascular Pharmacology

Volumn 64, Issue 6, 2014, Pages 554-559

  Yu, Lilei ^a   Huang, Bing ^a   He, Wenbo ^a   Wang, Songyun ^a   Liao, Kai ^a   Zhou, Xiaoya ^a   He, Bo ^a   Lu, Zhibing ^a   Jiang, Hong ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Atrial fibrillation; Autonomic nervous system; Ganglionated plexus; Spinal cord stimulation

Indexed keywords

CHOLINERGIC RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTRIC CURRENT; ELECTROCARDIOGRAM; ELECTRODE CATHETER; EPIDURAL NEEDLE; GANGLIONATED PLEXUS; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART MUSCLE REFRACTORY PERIOD; MALE; MICROELECTRODE; MONGREL DOG; NERVE CONDUCTION; NONHUMAN; PULMONARY VEIN; SPINAL CORD STIMULATION; SPINAL CORD STIMULATOR; SPINAL NERVE; ANIMAL; ATRIAL FIBRILLATION; AUTONOMIC GANGLION; DISEASE MODEL; DOG; HEART ATRIUM; METABOLISM; PATHOPHYSIOLOGY; PROCEDURES;

ANIMALS; ATRIAL FIBRILLATION; DISEASE MODELS, ANIMAL; DOGS; GANGLIA, AUTONOMIC; HEART ATRIA; MALE; PULMONARY VEINS; SPINAL CORD STIMULATION;

EID: 84918509449     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0000000000000154     Document Type: Article

References (30)

1. Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: The Framingham Heart Study. Circulation. 2004;110: 1042-1046.
2. Colilla S, Crow A, Petkun W, et al. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013;112:1142-1147.
3. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370-2375.
4. Jais P, Haissaguerre M, Shah DC, et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation. 1997;95: 572-576.
5. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659-666.
6. Hwang C, Wu TJ, Doshi RN, et al. Vein of marshall cannulation for the analysis of electrical activity in patients with focal atrial fibrillation. Circulation. 2000;101:1503-1505.
7. Tsai CF, Tai CT, Hsieh MH, et al. Initiation of atrial fibrillation by ectopic beats originating from the superior vena cava: electrophysiological characteristics and results of radiofrequency ablation. Circulation. 2000;102:67-74.
8. Bernstein SA, Wong B, Vasquez C, et al. Spinal cord stimulation protects against atrial fibrillation induced by tachypacing. Heart Rhythm. 2012;9: 1426-1433.
9. Lu Z, Scherlag BJ, Lin J, et al. Autonomic mechanism for initiation of rapid firing from atria and pulmonary veins: evidence by ablation of ganglionated plexi. Cardiovasc Res. 2009;84:245-252.
10. Patterson E, Po SS, Scherlag BJ, et al. Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation. Heart Rhythm. 2005;2:624-631.
11. Scherlag BJ, Hou YL, Lin J, et al. An acute model for atrial fibrillation arising from a peripheral atrial site: evidence for primary and secondary triggers. J Cardiovasc Electrophysiol. 2008;19:519-527.
12. Schauerte P, Scherlag BJ, Patterson E, et al. Focal atrial fibrillation: experimental evidence for a pathophysiologic role of the autonomic nervous system. J Cardiovasc Electrophysiol. 2001;12:592-599.
13. Patterson E, Lazzara R, Szabo B, et al. Sodium-calcium exchange initiated by the Ca2+ transient: An arrhythmia trigger within pulmonary veins. J Am Coll Cardiol. 2006;47:1196-1206.
14. Sha Y, Scherlag BJ, Yu L, et al. Low-level right vagal stimulation: Anticholinergic and antiadrenergic effects. J Cardiovasc Electrophysiol. 2011;22:1147-1153.
15. Li S, Scherlag BJ, Yu L, et al. Low-level vagosympathetic stimulation: A paradox and potential new modality for the treatment of focal atrial fibrillation. Circ Arrhythm Electrophysiol. 2009;2:645-651.
16. Yu L, Scherlag BJ, Li S, et al. Low-level vagosympathetic nerve stimulation inhibits atrial fibrillation inducibility: direct evidence by neural recordings from intrinsic cardiac ganglia. J Cardiovasc Electrophysiol. 2011;22:455-463.
17. Yu L, Scherlag BJ, Sha Y, et al. Interactions between atrial electrical remodeling and autonomic remodeling: how to break the vicious cycle. Heart Rhythm. 2012;9:804-809.
18. Yu L, Scherlag BJ, Li S, et al. Low-level transcutaneous electrical stimulation of the auricular branch of the vagus nerve: A noninvasive approach to treat the initial phase of atrial fibrillation. Heart Rhythm. 2013;10:428-435.
19. Hou Y, Scherlag BJ, Lin J, et al. Ganglionated plexi modulate extrinsic cardiac autonomic nerve input: effects on sinus rate, atrioventricular conduction, refractoriness, and inducibility of atrial fibrillation. J Am Coll Cardiol. 2007;50:61-68.
20. Murphy DF, Giles KE. Intractable angina pectoris: management with dorsal column stimulation. Med J Aust. 1987;146:260.
21. Olgin JE, Takahashi T, Wilson E, et al. Effects of thoracic spinal cord stimulation on cardiac autonomic regulation of the sinus and atrioventricular nodes. J Cardiovasc Electrophysiol. 2002;13:475-481.
22. Shen MJ, Shinohara T, Park HW, et al. Continuous low-level vagus nerve stimulation reduces stellate ganglion nerve activity and paroxysmal atrial tachyarrhythmias in ambulatory canines. Circulation. 2011;123: 2204-2212.
23. Brack KE, Patel VH, Coote JH, et al. Nitric oxide mediates the vagal protective effect on ventricular fibrillation via effects on action potential duration restitution in the rabbit heart. J Physiol. 2007;583(pt 2): 695-704.
24. Brack KE, Coote JH, Ng GA. Vagus nerve stimulation protects against ventricular fibrillation independent of muscarinic receptor activation. Cardiovasc Res. 2011;91:437-446.
25. Stavrakis S, Scherlag BJ, Fan Y, et al. Inhibition of atrial fibrillation by low-level vagus nerve stimulation: The role of the nitric oxide signaling pathway. J Interv Card Electrophysiol. 2013;36: 199-208.
26. Stavrakis S, Scherlag BJ, Fan Y, et al. Antiarrhythmic effects of vasostatin-1 in a canine model of atrial fibrillation. J Cardiovasc Electrophysiol. 2012;23:771-777.
27. Shen MJ, Hao-Che C, Park HW, et al. Low-level vagus nerve stimulation upregulates small conductance calcium-activated potassium channels in the stellate ganglion. Heart Rhythm. 2013; 10:910-915.
28. Lopshire JC, Zhou X, Dusa C, et al. Spinal cord stimulation improves ventricular function and reduces ventricular arrhythmias in a canine postinfarction heart failure model. Circulation. 2009;120:286-294.
29. Liu Y, Yue WS, Liao SY, et al. Thoracic spinal cord stimulation improves cardiac contractile function and myocardial oxygen consumption in a porcine model of ischemic heart failure. J Cardiovasc Electrophysiol. 2012;23:534-540.
30. Torre-Amione G, Alo K, Estep JD, et al. Spinal cord stimulation is safe and feasible in patients with advanced heart failure: early clinical experience. Eur J Heart Fail. 2014;16:788-795.